Program Page

Current Campaigns

Campaign 1

Pharmaceutical companies make the medicines that enable us to live healthier, longer lives. But their business practices also drive up drug prices and increase the risk of harmful side effects, and their strong-armed lobbying has blocked needed reforms. Read more.

Campaign 2

Millions of Americans are uninsured or underinsured. And for Americans who do have coverage, rising costs are becoming a greater and greater financial burden. Our health care system is broken and needs to be fixed. Read more.

Campaign 3

Thousands of Americans every year succumb to infections at hospitals that result in serious illness or death. We’re working to make hospitals come clean starting with requiring them to disclose their infection rates. Read more.

[[Make sure to update links.]]

Overview

In a country with a world-renowned medical reputation, we expect drug companies to rigorously test and truthfully market their drugs. We expect that people will Americans have the means to treat illnesses, and for hospitals to put our health and safety over all other concerns.

But prescription drug prices are soaring, the Vioxx tragedy demonstrates that drugs are not always safe, and infections at hospitals kill too many patients. Health insurance plans too often fail to provide the coverage or treatments we need.

Too often, it is powerful special interests that are keeping our country from fulfilling our expectations of health and safety. U.S. PIRG works to counter their influence and protect the health of all Americans.

[[With aggressive investment in wind technology we could get XX% of our energy from wind by 2025.]]

News

[[Change the report to show correct news.]]

Newsroom

Reports

[[Change the report to show the correct report listings.]]

More Reports

Highlight

Another program feature

[[This could be a factsheet, an interactive feature, an action, a resutls, or another highlight.]] Pharmaceutical companies make the medicines that enable us to live healthier, longer lives. But their business practices also drive up drug prices and increase the risk of harmful side effects, and their strong-armed lobbying has blocked needed reforms. Read more.

ISSUES